These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
146 related items for PubMed ID: 30253401
1. Expression of Duplex shRNAs through a Lentiviral Vector against Cellular and Viral Genes Inflicts Sustained Inhibition of Hepatitis C Virus Replication. Mandal A, Chaubey B. Intervirology; 2018; 61(2):79-91. PubMed ID: 30253401 [Abstract] [Full Text] [Related]
2. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome. Takigawa Y, Nagano-Fujii M, Deng L, Hidajat R, Tanaka M, Mizuta H, Hotta H. Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339 [Abstract] [Full Text] [Related]
3. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Henry SD, van der Wegen P, Metselaar HJ, Tilanus HW, Scholte BJ, van der Laan LJ. Mol Ther; 2006 Oct; 14(4):485-93. PubMed ID: 16872906 [Abstract] [Full Text] [Related]
4. Transduction with Lentiviral Vectors Altered the Expression Profile of Host MicroRNAs. Huang H, Zhang C, Wang B, Wang F, Pei B, Cheng C, Yang W, Zhao Z. J Virol; 2018 Sep 15; 92(18):. PubMed ID: 29997205 [Abstract] [Full Text] [Related]
5. Generation of Combinatorial Lentiviral Vectors Expressing Multiple Anti-Hepatitis C Virus shRNAs and Their Validation on a Novel HCV Replicon Double Reporter Cell Line. Elbadawy HM, Mohammed Abdul MI, Aljuhani N, Vitiello A, Ciccarese F, Shaker MA, Eltahir HM, Palù G, Di Antonio V, Ghassabian H, Del Vecchio C, Salata C, Franchin E, Ponterio E, Bahashwan S, Thabet K, Abouzied MM, Shehata AM, Parolin C, Calistri A, Alvisi G. Viruses; 2020 Sep 18; 12(9):. PubMed ID: 32962117 [Abstract] [Full Text] [Related]
6. Disturbance of the microRNA pathway by commonly used lentiviral shRNA libraries limits the application for screening host factors involved in hepatitis C virus infection. Pan Q, de Ruiter PE, von Eije KJ, Smits R, Kwekkeboom J, Tilanus HW, Berkhout B, Janssen HL, van der Laan LJ. FEBS Lett; 2011 Apr 06; 585(7):1025-30. PubMed ID: 21376045 [Abstract] [Full Text] [Related]
7. Lentiviral vector design for multiple shRNA expression and durable HIV-1 inhibition. ter Brake O, 't Hooft K, Liu YP, Centlivre M, von Eije KJ, Berkhout B. Mol Ther; 2008 Mar 06; 16(3):557-64. PubMed ID: 18180777 [Abstract] [Full Text] [Related]
15. Inhibition of HCV replication by small interfering RNA. Ray RB, Kanda T. Methods Mol Biol; 2009 Mar 06; 510():251-62. PubMed ID: 19009267 [Abstract] [Full Text] [Related]
18. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs. Krönke J, Kittler R, Buchholz F, Windisch MP, Pietschmann T, Bartenschlager R, Frese M. J Virol; 2004 Apr 06; 78(7):3436-46. PubMed ID: 15016866 [Abstract] [Full Text] [Related]
19. Inhibition of hepatitis C virus translation and subgenomic replication by siRNAs directed against highly conserved HCV sequence and cellular HCV cofactors. Korf M, Jarczak D, Beger C, Manns MP, Krüger M. J Hepatol; 2005 Aug 06; 43(2):225-34. PubMed ID: 15964661 [Abstract] [Full Text] [Related]
20. Lipid droplet-binding protein TIP47 regulates hepatitis C Virus RNA replication through interaction with the viral NS5A protein. Vogt DA, Camus G, Herker E, Webster BR, Tsou CL, Greene WC, Yen TS, Ott M. PLoS Pathog; 2013 Aug 06; 9(4):e1003302. PubMed ID: 23593007 [Abstract] [Full Text] [Related] Page: [Next] [New Search]